Skip to main content

MindMaze Therapeutics Holding SA

MMTZF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001854078

No open-market purchases or sales by MindMaze Therapeutics Holding SA insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $19 in total; no superinvestor holds it.

Other share classesRLFTY

Q3 2023 vs. Q2 2023

How the institutions holding MindMaze Therapeutics Holding SA changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of MMTZF: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders31−2
Shares504117−387 (−76.8%)
Value$1.57K$293−$1.28K (−81.3%)

New holders (0)

Institutions that held MindMaze Therapeutics Holding SA at the end of Q3 2023 but not at the end of Q2 2023.

None.

Sold out (2)

Institutions that held MindMaze Therapeutics Holding SA at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of MMTZF in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Ancora Advisors, LLC375$1.16K
Strategic Investment Solutions, Inc.12$50